An international team of researchers has found that three commonly used antiviral and antimalarial drugs are effective in vitro at preventing replication of SARS-CoV-2, the virus that causes COVID-19. The work also underscores ...
Mar 24, 2021
0
141
A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat Covid-19. Haiping ...
Dec 31, 2020
0
324
What does SARS-CoV-2, the virus that causes COVID-19, do once it enters a person's airways, and how does infection in lung cells affect patients' immune responses? New research led by investigators at Massachusetts General ...
Dec 16, 2020
1
362
A pair of Vanderbilt University researchers are focusing on proteins that may lead to an inside track on battling COVID-19. Envelope proteins—small membrane proteins—have an important yet unknown role in the development ...
Nov 17, 2020
0
2
Researchers at Karolinska Institutet in Sweden report promising results from an in vitro combination therapy against COVID-19. In a study published in EMBO Molecular Medicine, the researchers show that a combination of remdesivir, ...
Nov 17, 2020
0
8
The probability that an obese person will develop severe COVID-19 is high regardless of age, sex, ethnicity, and the presence of co-morbidities such as diabetes, high blood pressure, and heart or lung disease, according to ...
Oct 14, 2020
0
74
Interferon (IFN) responses are one of the first defenses the body mounts against viral infections, and research has shown that it plays a role controlling viral replication. But when researchers at Baylor College of Medicine ...
Sep 10, 2020
0
93
Why is the COVID-19 virus deadly, while many other coronaviruses are fairly innocuous and just cause colds?
Aug 14, 2020
0
94
In a new study in Cell Discovery, Chen-Yu Zhang's group at Nanjing University and two other groups from Wuhan Institute of Virology and the Second Hospital of Nanjing present a novel finding that absorbed miRNA MIR2911 in ...
Jul 28, 2020
0
7
An experimental messenger RNA (mRNA)-based vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) elicits protective immune responses in mice and non-human primates, researchers report on July 23rd in ...
Jul 24, 2020
0
212
